Cargando…
Plasma Pharmacokinetic Parameters of Dexamethasone Following Administration of a Dexamethasone Intracanalicular Insert in Healthy Adults
PURPOSE: Intracanalicular dexamethasone insert is a resorbable sustained-release polyethylene glycol-based hydrogel insert delivering a 0.4 mg tapered dose of dexamethasone for up to 30 days to the ocular surface. It is FDA-approved for treating inflammation and pain after ocular surgery. It has als...
Autores principales: | Blizzard, Charles, McLaurin, Eugene B, Driscoll, Arthur, Silva, Fabiana Q, Vantipalli, Srilatha, Metzinger, Jamie Lynne, Goldstein, Michael H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140928/ https://www.ncbi.nlm.nih.gov/pubmed/34040341 http://dx.doi.org/10.2147/OPTH.S307194 |
Ejemplares similares
-
Early Real-World Physician Experience with an Intracanalicular Dexamethasone Insert
por: Matossian, Cynthia, et al.
Publicado: (2022) -
Evaluating the patient experience after implantation of a 0.4 mg sustained release dexamethasone intracanalicular insert (Dextenza™): results of a qualitative survey
por: Gira, Joseph P, et al.
Publicado: (2017) -
Pharmacokinetic Studies of Sustained-Release Depot of Dexamethasone in Beagle Dogs
por: Blizzard, Charles, et al.
Publicado: (2016) -
Dexamethasone Intracanalicular Insert: A Review in Treating Post-Surgical Ocular Pain and Inflammation
por: Lee, Arnold, et al.
Publicado: (2020) -
Intracanalicular Dexamethasone Insert or Topical Prednisolone Following iStent and Hydrus Surgery for Glaucoma
por: Jackson, Kevin J., et al.
Publicado: (2022)